Sledování nákladné pneumoonkologické léčby pokročilého nemalobuněčného karcinomu plic v první linii v registru TULUNG v České republice (stav k 15.3.2017)

• Title in English: Follow-up of costly pneumooncological treatment of advanced NSCLC with first-line treatment according to the TULUNG registry in the Czech Republic (up to March 15, 2017)
• Authors: SKŘIČKOVÁ Jana; CHLOUPKOVÁ Renata; KONEČNÝ Marek; PEŠEK Milan; ZATLOUKAL Petr; KOLEK Vítězslav; SALAJKA František; HRNČIARIK Michal; KOUBKOVÁ Leona; TOMÍŠKOVÁ Marcela; GRYGÁRKOVÁ Yvona; HAVEL Libor; ZEMANOVÁ Milada; SIXTOVÁ dimka; ROUBEC Jaromír; ČOUPKOVÁ Leona; ČERNOVSKÁ Markéta; OPÁLKA Petr; KREJČÍ Jana; ŠATÁNKOVÁ Monika; BENEJOVÁ Andrea; MAREL Miroslav; VAŠÁKOVÁ Martina
• Year of publication: 2017
• Type: Popularization text
• MU Faculty or unit: Faculty of Medicine
• Description: Five drugs (pemetrexed,erlotinib, bevacizumab, gefinitib and afatinib) were used as first-line treatment of non-small cell lung cancer (NSCLC) in 2234 patients in the Czech Republic between 2006 and 2017. A detailed morphological and genetic analysis of NSCLC was available. The outcomes of treatment are analysed.